Junbo Hong

869 total citations
45 papers, 565 citations indexed

About

Junbo Hong is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Junbo Hong has authored 45 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 26 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in Junbo Hong's work include Gallbladder and Bile Duct Disorders (20 papers), Pancreatic and Hepatic Oncology Research (13 papers) and Pediatric Hepatobiliary Diseases and Treatments (12 papers). Junbo Hong is often cited by papers focused on Gallbladder and Bile Duct Disorders (20 papers), Pancreatic and Hepatic Oncology Research (13 papers) and Pediatric Hepatobiliary Diseases and Treatments (12 papers). Junbo Hong collaborates with scholars based in China, United States and Ethiopia. Junbo Hong's co-authors include Nonghua Lü, Yaobin Ouyang, Anjiang Wang, Xinbo Xu, Cheng Xue Qin, Cong He, Yining Wang, Youxiang Chen, Nianshuang Li and Wei Zuo and has published in prestigious journals such as Frontiers in Microbiology, Journal of Antimicrobial Chemotherapy and Medicine.

In The Last Decade

Junbo Hong

42 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junbo Hong China 16 305 221 145 139 68 45 565
Hironobu Tsukamoto Japan 13 166 0.5× 133 0.6× 120 0.8× 124 0.9× 48 0.7× 32 485
Yaowei Ai China 11 171 0.6× 111 0.5× 116 0.8× 268 1.9× 33 0.5× 18 572
Sam Ho United States 7 224 0.7× 143 0.6× 130 0.9× 239 1.7× 99 1.5× 12 503
Takahito Katano Japan 13 143 0.5× 101 0.5× 106 0.7× 108 0.8× 49 0.7× 51 433
Fukuto Maruta Japan 14 435 1.4× 224 1.0× 96 0.7× 171 1.2× 114 1.7× 31 661
Ralph Boulton United Kingdom 8 286 0.9× 102 0.5× 57 0.4× 113 0.8× 119 1.8× 18 472
Kosuke Sakitani Japan 22 581 1.9× 365 1.7× 277 1.9× 281 2.0× 178 2.6× 46 1.1k
Akihiro Seki Japan 13 161 0.5× 206 0.9× 250 1.7× 227 1.6× 89 1.3× 41 801
Zhiwei Quan China 12 223 0.7× 142 0.6× 132 0.9× 249 1.8× 68 1.0× 18 618
Ryuichiro Tamada Japan 13 193 0.6× 267 1.2× 186 1.3× 115 0.8× 106 1.6× 40 598

Countries citing papers authored by Junbo Hong

Since Specialization
Citations

This map shows the geographic impact of Junbo Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbo Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbo Hong more than expected).

Fields of papers citing papers by Junbo Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junbo Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbo Hong. The network helps show where Junbo Hong may publish in the future.

Co-authorship network of co-authors of Junbo Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Junbo Hong. A scholar is included among the top collaborators of Junbo Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junbo Hong. Junbo Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Cui, Jian, Fei Xu, Wei Bai, et al.. (2023). HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism. Journal of Translational Medicine. 21(1). 125–125. 11 indexed citations
4.
5.
He, Cong, Yi Hu, Junbo Hong, et al.. (2023). 14-day pantoprazole- and amoxicillin-containing high-dose dual therapy for Helicobacter pylori eradication in elderly patients: A prospective, randomized controlled trial. Frontiers in Pharmacology. 14. 1096103–1096103. 8 indexed citations
6.
Yang, Hui, et al.. (2023). Meta-analysis on clinical outcomes of suprapapillary versus transpapillary stent insertion in malignant biliary obstruction. Surgical Endoscopy. 37(11). 8178–8195. 2 indexed citations
7.
Hong, Junbo, et al.. (2023). Evaluation of ERCP-related perforation: a single-center retrospective study. Gastroenterology report. 12. goae044–goae044. 1 indexed citations
8.
Hong, Junbo, Wei Zuo, Anjiang Wang, et al.. (2022). Potential Factors Predicting Histopathologically Upgrade Discrepancies between Endoscopic Forceps Biopsy of the Colorectal Low‐Grade Intraepithelial Neoplasia and Endoscopic Resection Specimens. BioMed Research International. 2022(1). 1915458–1915458. 2 indexed citations
9.
Xu, Xinbo, Xidong Wu, Yaobin Ouyang, et al.. (2022). A positive feedback loop of the TAZ/β-catenin axis promotes Helicobacter pylori-associated gastric carcinogenesis. Frontiers in Microbiology. 13. 1065462–1065462. 5 indexed citations
10.
Zuo, Wei, Hui Yang, Nianshuang Li, et al.. (2022). Helicobacter pylori infection activates Wnt/β-catenin pathway to promote the occurrence of gastritis by upregulating ASCL1 and AQP5. Cell Death Discovery. 8(1). 257–257. 20 indexed citations
11.
Zhou, Feng, Conghua Song, Guohua Li, et al.. (2022). The assessment of the ASGE-grading system of ERCP: a large-sample retrospective study. Surgical Endoscopy. 36(9). 6480–6487. 3 indexed citations
12.
Xu, Xinbo, Nianshuang Li, Huan Wang, et al.. (2021). Expression and prognostic significance of the DNA damage response pathway and autophagy markers in gastric cancer. Neoplasma. 68(6). 1310–1319. 7 indexed citations
13.
Hong, Junbo, Wei Zuo, Liang Zhu, et al.. (2020). Cannulation procedure optimization for patients with duodenal papillary tumors. Surgical Endoscopy. 35(10). 5635–5642. 1 indexed citations
14.
Wang, Yining, et al.. (2020). Advances in stent therapy for malignant biliary obstruction. Abdominal Radiology. 46(1). 351–361. 8 indexed citations
15.
Liu, Yang, Youxiang Chen, Xu Shu, et al.. (2019). Prophylactic antibiotics may be unnecessary in gastric endoscopic submucosal dissection due to the low incidence of bacteremia. Surgical Endoscopy. 34(9). 3788–3794. 7 indexed citations
16.
Zhou, Mi, Pingping Liu, Junbo Hong, et al.. (2019). Causes associated with recurrent choledocholithiasis following therapeutic endoscopic retrograde cholangiopancreatography: A large sample sized retrospective study. World Journal of Clinical Cases. 7(9). 1028–1037. 24 indexed citations
17.
Wang, Anjiang, Bimin Li, Pei Li, et al.. (2017). Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients. World Journal of Gastroenterology. 23(34). 6321–6321. 25 indexed citations
18.
Xiong, Huifang, et al.. (2017). The sinomenine enteric-coated microspheres suppressed the TLR/NF-κB signaling in DSS-induced experimental colitis. International Immunopharmacology. 50. 251–262. 37 indexed citations
19.
Hong, Junbo, Xu Shu, Dongsheng Liu, et al.. (2016). Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies forHelicobacter pyloriinfection: an open-label, randomized, single-centre clinical trial. Journal of Antimicrobial Chemotherapy. 71(8). 2280–2285. 36 indexed citations
20.
Hong, Junbo, Wei Zuo, Anjiang Wang, & Nonghua Lü. (2016). Helicobacter pylori Infection Synergistic with IL-1β Gene Polymorphisms Potentially Contributes to the Carcinogenesis of Gastric Cancer. International Journal of Medical Sciences. 13(4). 298–303. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hironobu Tsukamoto Breakdown of academic impact, for papers by Yaowei Ai Breakdown of academic impact, for papers by Sam Ho Breakdown of academic impact, for papers by Takahito Katano Breakdown of academic impact, for papers by Fukuto Maruta Breakdown of academic impact, for papers by Ralph Boulton Breakdown of academic impact, for papers by Kosuke Sakitani Breakdown of academic impact, for papers by Akihiro Seki Breakdown of academic impact, for papers by Zhiwei Quan Breakdown of academic impact, for papers by Ryuichiro Tamada
Rankless by CCL
2026